Mind Medicine Aktie

Zitat:"MindMed joins CTTI as one of approximately 80 member organizations interested in advancing higher quality clinical trials and accelerating the path to new therapeutics and other medical products. CTTI convenes its members – along with nearly 500+ multi-stakeholder organizations and individuals from across the clinical trials ecosystem – to discuss issues, exchange ideas, and come to a consensus on solutions to the greatest challenges in clinical research. As a member of the Steering Committee, MindMed will contribute to setting project priorities within CTTI's agenda, as well as serving on the teams that create recommendations and resources to transform clinical trials globally....:" ENDE Zitat Quelle:https://www.stockwatch.com/News/Item/U-C1147-U!MNMD-20211013/U/MNMD

Zitat:"Effective September 29, 2021, Mr. Bruce Linton stepped down from the Company's board of directors in order to make room for the appointment of Ms. Vallone and Mr. Krebs. Mr. Linton said, "In a little over two years MindMed has gone from a topic that was frankly difficult to find support for, to attracting world class talent and deep capacity capital." He added further "I am delighted with the candidates joining and look forward to the world of change MindMed can achieve."...." ENDE Zitat Quelle:https://www.stockwatch.com/News/Item/U-C6491-U!MNMD-20210930/U/MNMD

https://www.proactiveinvestors.com/OTCMKTS:MMEDF/MindMed/ https://www.cnbc.com/2021/05/11/kevin-oleary-psychedelic-drugs-far-exceed-cannabis-potential.html

Zitat:"...former Canopy Growth CEO Bruce Linton is involved in at least two psychedelic companies. He’s chair of the advisory board of the psychedelic mushroom business Red Light Holland as well as a board member and large stockholder of one of the biggest psychedelic companies, New York-based MindMed. MindMed started trading on the Nasdaq on April 27...." ENDE Zitat Quelle:https://mjbizdaily.com/no-hallucination-psychedelics-could-be-next-cannabis-like-boom/